Invention Grant
US09199986B2 Deuterated pyrazino[2,1-a]isoquinolines for the treatment of diseases and/or conditions
有权
用于治疗疾病和/或病症的氘代吡嗪并[2,1-a]异喹啉
![Deuterated pyrazino[2,1-a]isoquinolines for the treatment of diseases and/or conditions](/docs/US/2015-12-01/US09199986B2/abs.jpg.600x600.jpg)
- Patent Title: Deuterated pyrazino[2,1-a]isoquinolines for the treatment of diseases and/or conditions
- Patent Title (中): 用于治疗疾病和/或病症的氘代吡嗪并[2,1-a]异喹啉
-
Application No.: US14030617Application Date: 2013-09-18
-
Publication No.: US09199986B2Publication Date: 2015-12-01
- Inventor: Julie F. Liu , Scott L. Harbeson , Roger D. Tung
- Applicant: Concert Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Emily Dertz
- Main IPC: C07D241/38
- IPC: C07D241/38 ; C07D471/04 ; A61K31/4184 ; A61K31/4985 ; A61K45/06
![Deuterated pyrazino[2,1-a]isoquinolines for the treatment of diseases and/or conditions](/abs-image/US/2015/12/01/US09199986B2/abs.jpg.150x150.jpg)
Abstract:
This invention relates to novel compounds that are pyrazinoisoquinoline derivatives of Formula I: and pharmaceutically acceptable salts thereof. More specifically, this invention relates to novel pyrazinoisoquinoline derivatives that are derivatives of praziquantel. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are beneficially treated by administering an antihelminthic agent, such as praziquantel.
Public/Granted literature
- US20140107127A1 PYRAZINOISOQUINOLINE COMPOUNDS Public/Granted day:2014-04-17
Information query
